RCKTLawsuits•prnewswire•
Faruqi & Faruqi Reminds Rocket Pharmaceuticals Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 11, 2025 - RCKT
Sentiment:Negative (-60)
Summary
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rocket Pharmaceuticals To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Rocket Pharmaceuticals between February 27, 2025 and May...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 9, 2025 by prnewswire